相关实验视频
Updated: Jun 18, 2025
09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.4K
纳米技术用于阿尔茨海默病的tau病理学
Rongrong Ma1,2, Qianwen Mu1,2, Yue Xi1
1State Key Laboratory of Stress Biology, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China.
Materials today. Bio
|July 29, 2024
概括
纳米技术提供了通过向tau蛋白来打击阿尔茨海默病 (AD) 的创新方法. 这种方法旨在调节,防止其传播,并可能导致个性化的AD治疗.
科学领域:
- 神经科学是一个神经科学.
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
背景情况:
- 阿尔茨海默病 (AD) 的特点是蛋白聚合,导致神经纤维状结和认知能力下降.
- 病态的积破坏神经通信,是AD神经退行症的关键标志.
研究的目的:
- 探索与相关的神经生理学和纳米技术在阿尔茨海默病治疗中的交叉点.
- 审查纳米材料在调节病理中的应用,以获得治疗效益.
主要方法:
- 关于TAU蛋白在AD和纳米技术应用中的当前文献的综述.
- 专注于纳米材料策略来调节的酸化,聚合和传播.
- 使用纳米技术检查微管稳定和病态清除方法.
主要成果:
- 纳米技术提供了各种策略,以准AD的病理性tau积累和传播.
- 纳米材料可以被设计成干扰的关键病理过程.
- 纳米技术在开发个性化疗法和监测AD患者治疗疗效方面的潜力.
结论:
- 纳米技术为开发用于阿尔茨海默病的新型诊断和治疗方法提供了一个有希望的前沿.
- 用纳米材料准tau蛋白提供了一种多方面的方法来对抗AD.
- 结合tau神经生理学和纳米技术的进一步研究可以在AD治疗中取得重大进展.
相关概念视频
01:26Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
01:22Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172